Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review

[1]  E. Roughead,et al.  Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the Elderly , 2011, Drug safety.

[2]  G. Trifirò.  Antipsychotic Drug Use and Community-Acquired Pneumonia , 2011, Current infectious disease reports.

[3]  E. Roughead,et al.  Risk of Hospitalization for Stroke Associated with Antipsychotic Use in the Elderly , 2010, Drugs & aging.

[4]  A. Bate,et al.  Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern? , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[5]  L. Mody,et al.  Pharmacotherapy and the risk for community-acquired pneumonia , 2010, BMC geriatrics.

[6]  Nicole Pratt,et al.  Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments , 2010, Pharmacoepidemiology and drug safety.

[7]  G. Mazzaglia,et al.  Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer, et al. , 2010, Journal of psychopharmacology.

[8]  E. Sacchetti,et al.  Cerebrovascular Accidents in Elderly People Treated with Antipsychotic Drugs , 2010, Drug safety.

[9]  Susan C. Miller,et al.  Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. , 2010, Journal of the American Medical Directors Association.

[10]  A. Egberts,et al.  Risk of cerebrovascular events in elderly users of antipsychotics , 2009, Journal of psychopharmacology.

[11]  V. Mor,et al.  All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. , 2009, The Journal of clinical psychiatry.

[12]  Rebecca Tooher,et al.  Extending an evidence hierarchy to include topics other than treatment: revising the Australian 'levels of evidence' , 2009, BMC medical research methodology.

[13]  C. Ballard,et al.  The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial , 2009, The Lancet Neurology.

[14]  C. Cooper,et al.  Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study , 2009, Osteoporosis International.

[15]  Liam Smeeth,et al.  Exposure to antipsychotics and risk of stroke: self controlled case series study , 2008, BMJ : British Medical Journal.

[16]  J. Lieberman,et al.  Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. , 2008, The American journal of psychiatry.

[17]  A. Egberts,et al.  Antipsychotic Drug Use and Risk of Pneumonia in Elderly People , 2008, Journal of the American Geriatrics Society.

[18]  G. Trifirò,et al.  Risk of stroke with typical and atypical anti-psychotics: a retrospective cohort study including unexposed subjects , 2008, Journal of psychopharmacology.

[19]  J. Avorn,et al.  Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. , 2007, Journal of clinical psychopharmacology.

[20]  H. Wehring,et al.  Comparison of Risk of Cerebrovascular Events in an Elderly VA Population With Dementia Between Antipsychotic and Nonantipsychotic Users , 2007, Journal of clinical psychopharmacology.

[21]  R. Cumming,et al.  Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[22]  M. Valenstein,et al.  Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. , 2007, The American journal of psychiatry.

[23]  R. Cumming,et al.  Risk of Death Associated with Antipsychotic Drug Dispensing in Residential aged Care Facilities , 2007, The Australian and New Zealand journal of psychiatry.

[24]  J. Friedman,et al.  Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. , 2007, The Journal of clinical psychiatry.

[25]  Kelvin Lam,et al.  Antipsychotic Drug Use and Mortality in Older Adults with Dementia , 2007, Annals of Internal Medicine.

[26]  K. Verhamme,et al.  All‐cause mortality associated with atypical and typical antipsychotics in demented outpatients , 2007, Pharmacoepidemiology and drug safety.

[27]  Henry Brodaty,et al.  The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trials , 2007, International journal of geriatric psychiatry.

[28]  T. Strandberg,et al.  Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[29]  C. Ballard,et al.  Antipsychotics in patients with Alzheimer's disease—what is their clinical value? , 2007, Nature Clinical Practice Neurology.

[30]  S. Schneeweiss,et al.  Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients , 2007, Canadian Medical Association Journal.

[31]  D. Jeste,et al.  Mortality in Elderly Dementia Patients Treated With Risperidone , 2006, Journal of clinical psychopharmacology.

[32]  F. Ahern,et al.  Outcomes of antipsychotic drug use in community-dwelling elders with dementia. , 2006, Archives of psychiatric nursing.

[33]  M Alan Brookhart,et al.  Instrumental Variable Analysis of Secondary Pharmacoepidemiologic Data , 2006, Epidemiology.

[34]  Patrick Musonda,et al.  Tutorial in biostatistics: the self‐controlled case series method , 2006, Statistics in medicine.

[35]  Wiebe R. Pestman,et al.  Instrumental Variables: Application and Limitations , 2006, Epidemiology.

[36]  Philip S. Insel,et al.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[37]  C. Ballard,et al.  Atypical antipsychotics for aggression and psychosis in Alzheimer's disease , 2006 .

[38]  J. Avorn,et al.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications. , 2005, The New England journal of medicine.

[39]  H. Brodaty,et al.  Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double‐blind, placebo‐controlled trial , 2005, International journal of geriatric psychiatry.

[40]  Lon S Schneider,et al.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. , 2005, JAMA.

[41]  S. Finkel,et al.  Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics , 2005, International Psychogeriatrics.

[42]  P. Deyn,et al.  Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone , 2005, Clinical Neurology and Neurosurgery.

[43]  M. Tansella,et al.  Second-Generation Antipsychotics and Risk of Cerebrovascular Accidents in the Elderly , 2005, Journal of clinical psychopharmacology.

[44]  V. Mor,et al.  Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. , 2005, The Journal of clinical psychiatry.

[45]  B. Kuehn.  FDA warns antipsychotic drugs may be risky for elderly. , 2005, JAMA.

[46]  S. Normand,et al.  Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding , 2005, BMJ : British Medical Journal.

[47]  S. Normand,et al.  Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study , 2005, BMJ : British Medical Journal.

[48]  Johan van der Lei,et al.  Antipsychotics and the risk of sudden cardiac death. , 2004, Archives of internal medicine.

[49]  N. Herrmann,et al.  Atypical antipsychotics and risk of cerebrovascular accidents. , 2004, The American journal of psychiatry.

[50]  J. Luxenberg,et al.  Haloperidol for agitation in dementia. , 2002, The Cochrane database of systematic reviews.

[51]  H. Arai,et al.  Risk Factors of Aspiration Pneumonia in Alzheimer’s Disease Patients , 2001, Gerontology.

[52]  J. Avorn,et al.  Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. , 2001, The American journal of psychiatry.

[53]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[54]  B. Lawlor,et al.  A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia , 1999, Neurology.

[55]  D. Jeste,et al.  Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.

[56]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .

[57]  J. Maurer.  Association of Community-Acquired Pneumonia With Antipsychotic Drug Use in Elderly patients: A Nested Case–Control Study , 2011 .

[58]  G. Trifirò,et al.  Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? , 2009, Pharmacological research.

[59]  M. Etminan,et al.  Psychotropic Medications and the Risk of Fracture , 2007, Drug safety.

[60]  N. Herrmann,et al.  Do Atypical Antipsychotics Cause Stroke? , 2005, CNS drugs.

[61]  F. Verhey,et al.  Antipsychotics for Behavioural and Psychological Problems in Elderly People with Dementia , 2005, Drugs & aging.

[62]  C. Ballard,et al.  The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. , 2002, The Cochrane database of systematic reviews.

[63]  K. Dagerman,et al.  The n e w e n g l a n d j o u r n a l of m e d i c i n e Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer’s Disease , 2006 .